Exelon Patch (Rivastigmine PATCH) 9.5mg/24hrs

Exelon Patch (rivastigmine) 9.5mg/24hrs is a transdermal patch for managing symptoms of mild to moderate dementia in Alzheimer's and Parkinson's disease. This non-invasive treatment delivers steady medication through the skin. Suitable for patients seeking consistent symptom control.

Strength

9.5mg/24hrs

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Novartis Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Exelon Patch is used to treat symptoms of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease. It helps manage cognitive decline by supporting brain function. Patients and caregivers often seek this patch for its ease of use and steady medication delivery. Rivastigmine patches are designed for long-term symptom management.

Side Effects

The patch delivers rivastigmine through the skin, providing a steady dose over 24 hours. Users may notice improved focus and reduced confusion over time. Some report better daily functioning and reduced behavioral symptoms. Effects vary by individual and may take weeks to become noticeable.

Precautions & Warnings

Store the patch at room temperature away from moisture and heat. Keep out of reach of children and pets. Apply to clean, dry, hairless skin on the upper or lower back, upper arm, or chest. Rotate application sites to avoid irritation. Avoid using damaged or cut patches.

Avoid Interactions

Alcohol may increase drowsiness when combined with rivastigmine. Certain medications, including anticholinergics and muscle relaxants, may interact with rivastigmine. Always inform your healthcare provider about all medications being taken. Some interactions may reduce effectiveness or increase side effects.

Frequently Asked Questions

Exelon Patch is used to manage symptoms of mild to moderate dementia in Alzheimer's and Parkinson's disease.

Effects may take several weeks to become noticeable as the medication builds up in the system.

No, the patch should not be cut as it may affect the medication delivery.

Apply to clean, dry, hairless skin on the upper or lower back, upper arm, or chest.

Some users may experience skin irritation at the application site or mild gastrointestinal effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.